Bilimsel çalışmalar

Prof. Dr. Ebubekir Şenateş

133 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. A1: Senates E, Yilmaz Y, Colak Y, Ozturk O, Altunoz Me, Kurt R, Ozkara S, Aksaray S, Tuncer I, Ovunc Ao. Serum Levels of Hepcidin in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease. Metab Syndr Relat Disord. 2011 Aug;9(4):287-90. Doi: 10.1089/Met.2010.0121. Epub 2011 Mar 21.

    Kaynak: medicana.com.tr profil sayfası

  2. A2: Ince AT, Senateş E, Bahadir O, Coşgun S, Güneş P, Yildiz E, Ovünç Ao. Conventional Video-Gastroscopes For The Recognition Of Early Gastric Cancers. Hepatogastroenterology. 2011 May-Jun;58(107-108):1081-5.

    Kaynak: medicana.com.tr profil sayfası

  3. A3: Ince At, Güneş P, Senateş E, Sezikli M, Tiftikçi A, Ovünç O. Can An Immunohistochemistry Method Differentiate Intestinal Tuberculosis from Crohn's Disease In Biopsy Specimens? Dig Dis Sci. 2011 Apr;56(4):1165-70. Doi: 10.1007/S10620-010-1399-7. Epub 2010 Sep 8.

    Kaynak: medicana.com.tr profil sayfası

  4. A4: Calhan T, Senateş E, Cebeci E, Zuhur Ss, Ozbakır F, Görpe U. A Comparison Of Antineutrophil Cytoplasmic Antibody Prevalence in Patients Treated And Untreated For Hyperthyroidism. Endocrine. 2010 Oct;38(2):199-205. Doi:10.1007/S12020-010-9373-X. Epub 2010 Jul 11.

    Kaynak: medicana.com.tr profil sayfası

  5. A5: Yilmaz Y, Senates E, Ayyildiz T, Colak Y, Tuncer I, Ovunc Ao, Dolar E, Kalayci C. Characterization of Nonalcoholic Fatty Liver Disease Unrelated To the Metabolic Syndrome. Eur J Clin Invest. 2012 Apr;42(4):411-8. Doi: 10.1111/J.1365-2362.2011.02597.X. Epub 2011 Sep 13.

    Kaynak: medicana.com.tr profil sayfası

  6. A6: Hatemi AI, Senateş E, Dobrucali A, Göksel S. Collagenous Colitis: A Retrospective Survey of Patients with Chronic Diarrhea. Hepatogastroenterology. 2011 Nov-Dec;58(112):1963-7. Doi: 10.5754/Hge11228.

    Kaynak: medicana.com.tr profil sayfası

  7. A7:Şenateş E, Masatlıoğlu HS, Akdoğan MF, Kurtuluş D, Atasoy MM, Övünç AOK, "A Polyarteritis Nodosa Case Mimicking Pyelonephritis, then Misdiagnosed as Inflammatory Bowel Disease", Turk J Phys Med Rehab 2013;59:79-82. Doı:10.4274/Tftr.61214.

    Kaynak: medicana.com.tr profil sayfası

  8. A8: Yeşil A, Senateş E, Bayoğlu IV, Erdem ED, Demirtunç R, Kurdaş Övünç AO. Red Cell Distribution Width: A Novel Marker of Activity in Inflammatory Bowel Disease. Gut Liver. 2011 Dec;5(4):460-7. Doi: 10.5009/Gnl.2011.5.4.460. Epub 2011 Nov 21.

    Kaynak: medicana.com.tr profil sayfası

  9. A9: Colak Y, Ozturk O, Senates E, Tuncer I, Yorulmaz E, Adali G, Doganay L, Enc Fy. SIRT1 As a Potential Therapeutic Target for Treatment of Nonalcoholic Fatty Liver Disease. Med Sci Monit. 2011 May;17(5):Hy5-9. Review.

    Kaynak: medicana.com.tr profil sayfası

  10. A10: Colak Y, Senates E, Ozturk O, Yilmaz Y, Coskunpinar E, Kahraman OT, Sahin O, Zemheri E, Enc FY, Ulasoglu C, Kiziltas S, Kurdas OO, Tuncer I. Plasma Fibrinogen-Like Protein 2 Levels in Patients With Non-Alcoholic Fatty Liver Disease. Hepatogastroenterology. 2011 Nov-Dec;58(112):2087-90. Doi:

    Kaynak: medicana.com.tr profil sayfası

  11. A11: Güzelbulut F, Ovünç AO, Çetinkaya ZA, Senates E, Gökden Y, Saltürk AG, Sezikli M, Ozkara S, Cetinkaya F. Comparison of The Efficacy of Entecavir and Tenofovir in Chronic Hepatitis B. Hepatogastroenterology. 2012 Mar-Apr;59(114):477-80. Doi: 10.5754/Hge11426.

    Kaynak: medicana.com.tr profil sayfası

  12. A12: Ozdil K, Calhan T, Sahin A, Senates E, Kahraman R, Yüzbasioglu B, Demirdag H, Demirsoy H, Sökmen MH. Levofloxacin Based Sequential and Triple Therapy Compared With Standard Plus Probiotic Combination for Helicobacter Pylori Eradication. Hepatogastroenterology. 2011 Jul-Aug;58(109):1148-52. Doi: 10.5754/Hge11075.

    Kaynak: medicana.com.tr profil sayfası

  13. A13: Yilmaz Y, Eren F, Ayyildiz T, Colak Y, Kurt R, Senates E, Tuncer I, Dolar E, Imeryuz N. Serum Pigment Epithelium-Derived Factor Levels are Increased in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease and Independently Associated with Liver Steatosis. Clin Chim Acta. 2011 Nov 20;412(23-24):2296-9. Doi: 10.1016/J.Cca.2011.08.025. Epub 2011 Aug 24.

    Kaynak: medicana.com.tr profil sayfası

  14. A14: Sökmen HM, Ozdil K, Calhan T, Sahin A, Senateş E, Kahraman R, Niğdelioğlu A, Zemheri E. Situs Inversus Totalis and Secondary Biliary Cirrhosis: A Case Report. Comp Hepatol. 2011 Aug 3;10:5. Doi: 10.1186/1476-5926-10-5.

    Kaynak: medicana.com.tr profil sayfası

  15. A15: Yilmaz Y, Eren F, Kurt R, Yonal O, Polat Z, Senates E, Bacha M, Imeryuz N. Serum Galectin-3 Levels in Patients with Nonalcoholic Fatty Liver Disease. Clin Biochem. 2011 Aug;44(12):955-8. Doi: 10.1016/J.Clinbiochem.2011.05.015. Epub 2011 May 24.

    Kaynak: medicana.com.tr profil sayfası

  16. A16: Masatlioglu S, Seyahi E, Tahir Turanli E, Fresko I, Gogus F, Senates E, Oguz Savran F, Yazici H. A Twin Study in Behçet's Syndrome. Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S62-6. Epub 2010 Sep 24.

    Kaynak: medicana.com.tr profil sayfası

  17. A17: Yilmaz Y, Kurt R, Gurdal A, Alahdab Yo, Yonal O, Senates E, Polat N, Eren F, Imeryuz N, Oflaz H. Circulating Vaspin Levels and Epicardial Adipose Tissue Thickness are Associated with Impaired Coronary Flow Reserve in Patients With Nonalcoholic Fatty Liver Disease. Atherosclerosis. 2011 Jul;217(1):125-9. Doi: 10.1016/J.Atherosclerosis.2011.03.026. Epub 2011 Mar 29.

    Kaynak: medicana.com.tr profil sayfası

  18. A18: Colak Y, Senates E, Coskunpinar E, Oltulu YM, Zemheri E, Ozturk O, Doganay L, Mesci B, Yilmaz Y, Enc FY, Kiziltas S, Ulasoglu C, Tuncer I. Concentrations of Connective Tissue Growth Factor in Patients with Nonalcoholic Fatty Liver Disease: Association With Liver Fibrosis. Dis Markers. 2012;33(2):77-83. Doi: 10.3233/Dma-2012-0907.

    Kaynak: medicana.com.tr profil sayfası

  19. A19: Colak Y, Senates E, Ozturk O, Doganay Hl, Coskunpinar E, Oltulu YM, Eren A, Sahin O, Ozkanli S, Enc Fy, Ulasoglu C, Tuncer I. Association Of Serum Lipoprotein-Associated Phospholipase A2 Level With Nonalcoholic Fatty Liver Disease. Metab Syndr Relat Disord. 2012 Apr;10(2):103-9. Doi: 10.1089/Met.2011.0111. Epub 2011 Nov 23.

    Kaynak: medicana.com.tr profil sayfası

  20. A20: Altunöz ME, Senateş E, Yeşil A, Calhan T, Ovünç AO. Patients With Inflammatory Bowel Disease Have a Lower Response Rate To HBV Vaccination Compared To Controls. Dig Dis Sci. 2012 Pr;57(4):1039-44. Doi: 10.1007/S10620-011-1980-8. Epub 2011 Dec 7.

    Kaynak: medicana.com.tr profil sayfası

  21. A21: Colak Y, Tuncer I, Senates E, Ozturk O, Doganay L, Yilmaz Y. Nonalcoholic Fatty Liver Disease: A Nutritional Approach. Metab Syndr Relat Disord. 2012 Jun;10(3):161-6. Doi: 10.1089/Met.2011.0145. Epub 2012 Mar 6. Review.

    Kaynak: medicana.com.tr profil sayfası

  22. A22: Şenateş E, Çolak Y, Erdem ED, Yeşil A, Coşkunpınar E, Şahin Ö, Altunöz ME, Tuncer I, Kurdaş Övünç AO. Serum Anti-Müllerian Hormone Levels are Lower In Reproductive-Age Women With Crohn's Disease Compared To Healthy Control Women. J Crohns Colitis. 2013 Mar;7(2):E29-34. Doi: 10.1016/J.Crohns.2012.03.003. Epub 2012 Apr 1.

    Kaynak: medicana.com.tr profil sayfası

  23. A23: Colak Y, Senates E, Yesil A, Yilmaz Y, Ozturk O, Doganay L, Coskunpinar E, Kahraman Ot, Mesci B, Ulasoglu C, Tuncer I. Assessment Of Endothelial Function in Patients With Nonalcoholic Fatty Liver Disease. Endocrine. 2013 Feb;43(1):100-7. Doi: 10.1007/S12020-012-9712-1. Epub 2012 Jun 3.

    Kaynak: medicana.com.tr profil sayfası

  24. A24: Colak Y, Karabay CY, Tuncer I, Kocabay G, Kalayci A, Senates E, Ozturk O, Doganay Hl, Enc FY, Ulasoglu C, Kiziltas S. Relation Of Epicardial Adipose Tissue And Carotid Intima-Media Thickness In Patients with Nonalcoholic Fatty Liver Disease. Eur J Gastroenterol Hepatol. 2012 Jun;24(6):613-8. Doi:10.1097/Meg.0b013e3283513f19.

    Kaynak: medicana.com.tr profil sayfası

  25. A25: Colak Y, Senates E, Ozturk O, Yilmaz Y, Zemheri E, Yilmaz Enc F, Ulasoglu C, Aksaray S, Bozbeyoglu Sg, Kiziltas S, Kurdas Oo, Tuncer I. Serum Concentrations Of Human Insulin-Like Growth Factor-1 And Levels Of Insulin-Like Growth Factor-Binding Protein-5 In Patients With Nonalcoholic Fatty Liver Disease: Association With Liver Histology. Eur J Gastroenterol Hepatol. 2012 Mar;24(3):255-61. Doi: 10.1097/Meg.0b013e32834e8041.

    Kaynak: medicana.com.tr profil sayfası

  26. A26: Tabak O, Gelişgen R, Cicekçi H, Senateş E, Erdenen F, Müderrisoğlu C, Aral H, Uzun H. Circulating Levels Of Adiponectin, Orexin-A, Ghrelin And the Antioxidant Paraoxonase-1 in Metabolic Syndrome. Minerva Med. 2012 Aug;103(4):323-9.

    Kaynak: medicana.com.tr profil sayfası

  27. A27: Calhan T, Kahraman R, Sahin A, Senates E, Doganay HL, Kanat E, Ozdil K, Sokmen HM. Efficacy Of Two Levofloxacin-Containing Second-Line Therapies For Helicobacter Pylori: A Pilot Study. Helicobacter. 2013 Apr 21. Doi:10.1111/Hel.12056.

    Kaynak: medicana.com.tr profil sayfası

  28. A28: Yilmaz Y, Colak Y, Kurt R, Senates E, Eren F. Linking Nonalcoholic Fatty Liver Disease To Hepatocellular Carcinoma: From Bedside To Bench And Back. Tumori. 2013 Jan-Feb;99(1):10-6. Doi: 10.1700/1248.13781. Review.

    Kaynak: medicana.com.tr profil sayfası

  29. A29: Yeşil A, Gönen C, Senateş E, Paker N, Gökden Y, Koçhan K, Erdem Ed, Gündüz F. Relationship Between Neutrophil Gelatinase-Associated Lipocalin (Ngal) Levels And Inflammatory Bowel Disease Type And Activity. Dig Dis Sci. 2013 Apr 30.

    Kaynak: medicana.com.tr profil sayfası

  30. A30: Senateş E, Colak Y, Yeşil A, Coşkunpinar E, Sahin O, Kahraman Ot, Erkalma Şenateş B, Tuncer I. Circulating Resistin is Elevated in Patients with Non-Alcoholic Fatty Liver Disease and is Associated With Steatosis, Portal İnflammation, İnsulin Resistance And Nonalcoholic Steatohepatitis Scores. Minerva Med. 2012 Oct;103(5):369-76.

    Kaynak: medicana.com.tr profil sayfası

  31. A31: Yilmaz Y, Ozturk O, Alahdab Yo, Senates E, Colak Y, Doganay HL, Coskunpinar E, Oltulu YM, Eren F, Atug O, Tuncer I, Imeryuz N. Serum Osteopontin Levels As A Predictor Of Portal İnflammation İn Patients With Nonalcoholic Fatty Liver Disease. Dig Liver Dis. 2013 Jan;45(1):58-62. Doi: 10.1016/J.Dld.2012.08.017.

    Kaynak: medicana.com.tr profil sayfası

  32. A32: Yilmaz Y, Eren F, Colak Y, Senates E, Celikel CA, Imeryuz N. Hepatic Expression And Serum Levels Of Syndecan 1 (CD138) in Patients with Nonalcoholic Fatty Liver Disease. Scand J Gastroenterol. 2012 Dec;47(12):1488-93. Doi:10.3109/00365521.2012.725093. Epub 2012 Nov 8.

    Kaynak: medicana.com.tr profil sayfası

  33. A33: Ceylan B, Mete B, Fincanci M, Aslan T, Akkoyunlu Y, Ozguneş N, Colak O, Gunduz A, Senates E, Ozaras R, Inci A, Tabak F. A New Model Using Platelet Indices to Predict Liver Fibrosis In Patients With Chronic Hepatitis B Infection. Wien Klin Wochenschr. 2013; 125(15-16)

    Kaynak: medicana.com.tr profil sayfası

  34. A34: Yilmaz Y, Ayyildiz T, Akin H, Colak Y, Ozturk O, Senates E, Tuncer I, Dolar E. Gallstone disease does not predict liver histology in nonalcoholic Fatty liver disease. Gut Liver. 2014;8(3):313-7. doi: 10.5009/gnl.2014.8.3.313.

    Kaynak: medicana.com.tr profil sayfası

  35. A35: Selvinaz Ozkara, Fugen Aker, Atakan Yesil, Ebubekir Senates, Ceren Canbey, Ali Yitik and Can Gonen. Re-Evaluation of Cases With Gastroenteropancreatic Neuroendocrine Tumors Between 2004 and 2012 According to the 2010 Criteria. Hepato-Gastroenterology 2013; 60:00-00 Doi 10.5754/Hge 13337.

    Kaynak: medicana.com.tr profil sayfası

  36. A36: Kiziltas S, Ata P, Colak Y, Mesçi B, Senates E, Enc F, Ulasoglu C, Tuncer I,Oguz A. TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls. Metab Syndr Relat Disord. 2014;12(3):165-70. doi: 10.1089/met.2013.0120. Epub 2014 Jan 20.

    Kaynak: medicana.com.tr profil sayfası

  37. A37: Kadir Kayataş, Özhan Kaya, Ebubekir Şenateş, Atakan Yeşil, , Banu Erkalma Şenateş, Ezgi Ersoy Yeşil, Erdal Belen, Akın Dayan, Refik Demirtunç. Relationship between serum lipids and colon polyps: a pilot study. Acta Medica Mediterranea, 2014, 30: 57

    Kaynak: medicana.com.tr profil sayfası

  38. A38: Yilmaz Y, Senates E, Yesil A, Ergelen R, Colak Y. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease. J Diabetes Complications. 2014 May-Jun;28(3):328-31. doi: 10.1016/j.jdiacomp.2014.01.013. Epub 2014 Jan 30.

    Kaynak: medicana.com.tr profil sayfası

  39. A39: HLA DQB1 alleles are related with nonalcoholic fatty liver disease. Levent Doganay, Seyma Katrinli, Yasar Colak, Ebubekir Senates, Ebru Zemheri, Oguzhan Ozturk, Feruze Yilmaz Enc, Ilyas Tuncer, Gizem Dinler Doganay. Mol Biol Rep. DOI 10.1007/s11033-014-3688-2. Received: 21 September 2013 / Accepted: 20 August 2014.

    Kaynak: medicana.com.tr profil sayfası

  40. A40: Colak Y, Yesil A, Mutlu HH, Caklili OT, Ulasoglu C, Senates E, Takir M, Kostek O, Yilmaz Y, Yilmaz Enc F, Tasan G, Tuncer I. A potential treatment ofnon-alcoholic fatty liver disease with SIRT1 activators. J Gastrointestin Liver Dis. 2014 Sep;23(3):311-319. doi: 10.15403/jgld.2014.1121.233.yck. Review.

    Kaynak: medicana.com.tr profil sayfası

  41. A41: Ebubekir Şenateş, Abdullah Doğan, Banu Erkalma Şenateş, Erdal Bodakçı, Muhammet Bekçibaşı. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma. Infez Med. 2014;22(4):313-6.

    Kaynak: medicana.com.tr profil sayfası

  42. A42. Ebubekir Şenateş, Yaşar Çolak, Atakan Yeşil, Ilyas Tuncer. Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C. Turk J Gastroenterol 2015; 26: 283-283. DOI: 10.5152/tjg.2014.0083.

    Kaynak: medicana.com.tr profil sayfası

  43. A43. Banu Erkalma Şenateş, Abdullah Doğan, Ebubekir Şenateş. Symptomatic hypocalcaemia following intravenous administration of zoledronic acid in a female patient with osteoporosis. Acta Medica Mediterranea, 2015, 31: 895.

    Kaynak: medicana.com.tr profil sayfası

  44. A44. Oguzhan Ozturk, Yasar Colak, Ebubekir Senates, Yusuf Yilmaz, Celal Ulasoglu, Levent Doganay, Seyma Ozkanli, Yasemin Musteri Oltulu, Ender Coskunpinar, Ilyas Tuncer. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease. World J Gastroenterol. 2015 14;21(26):8096-102. doi: 10.3748/wjg.v21.i26.8096.

    Kaynak: medicana.com.tr profil sayfası

  45. A45. Meric K, Bakal N, Şenateş E, Aydın S, Kılıçoğlu ZG, Bahadır Ülger FE, Yencilek E, Erkalma Şenateş B, Şimşek M. Comparison of a 4-Day versus 2-Day Low Fiber Diet Regimen in Barium Tagging CT Colonography in Incomplete Colonoscopy Patients. Gastroenterol Res Pract. 2015;2015:609150. doi: 10.1155/2015/609150.

    Kaynak: medicana.com.tr profil sayfası

  46. A46. Çolak Y, Bozbey G, Erim T, Caklili OT, Ulasoglu C, Senates E, Mutlu HH, Mesci B, Doğan MS, Tasan G, Enc FY, Tuncer I. Impaired Gallbladder Motility and Increased Gallbladder Wall Thickness in Patients with Nonalcoholic Fatty Liver Disease. J Neurogastroenterol Motil. 2016 Jul 30;22(3):470-6. doi: 10.5056/jnm15159.

    Kaynak: medicana.com.tr profil sayfası

  47. A47. Sargin F, Yildiz D, Aydin OA, Mete B, Gunduz A, Karaosmanoglu HK, Yemisen M, Yazici S, Bolukcu S, Durdu B, Senates E, Ozaras R, Dokmetas I, Tabak F. Changes in HIV demographic patterns in a low prevalence population: no evidence of ashift towards men who have sex with men. Int J Infect Dis. 2016 Jul;48:52-6. doi:10.1016/j.ijid.2016.05.006.

    Kaynak: medicana.com.tr profil sayfası

  48. A48. Yilmaz B, Can G, Ucmak F, Arslan AO, Solmaz I, Unlu O, Düzenli S, Korkmaz U, Kurt M, Senates E. Polymorphisms in the IL28B gene (rs12979860, rs8099917) and the virological response to pegylated interferon therapy in hepatitis D virüs patients. Acta Gastroenterol Belg. 2016 Apr-Jun;79(2):206-10.

    Kaynak: medicana.com.tr profil sayfası

  49. A49. Mehmet Veysi Bahadır, Mesut Gül, Ebubekir Şenateş, Cemil Göya, Abdullah Oğuz, Hüseyin Büyükbayram, Halil Kömek, Eyyüp Öner, Bilsel Baç. A Rare Duodenal Mass, Brunneroma: Case Report. Journal of Gastroenterology and Hepatology Research. Journal of GHR 2016 June; 5(3): 2096-2099 doi: 10.17554/j.issn.2224-3992.2016.05.614

    Kaynak: medicana.com.tr profil sayfası

  50. A50. Uçmak F, Ekin N, İbiloğlu İ, Arslan S, Kaplan İ, Şenateş E. ProphylacticAdministration of Silybin Ameliorates L-Arginine-Induced Acute Pancreatitis. Med Sci Monit. 2016 Oct 11;22:3641-3646.

    Kaynak: medicana.com.tr profil sayfası